Maze Therapeutics, Inc. · NASDAQ:MAZE

Bernstein Harold sold 16,141 Maze Therapeutics, Inc. shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 2, 2026

On Oct 1, 2026, Bernstein Harold (President, R&D & CMO) sold 16,141 Maze Therapeutics, Inc. shares at US$26.93 for US$435K under a trading plan, leaving 0 shares. Filed Oct 2, 2026 (Form 4).

Sold: 16,141 shares
Price: US$26.93
Value: US$435K
Holding after: 0 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President, R&D & CMO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 1, 2026	Common Stock	Option exercise	16,141	US$10.42	16,141	Direct
Oct 1, 2026	Common Stock	Sale	16,141	US$26.93	0	Direct

Source

View original at SEC

Related